Great Point Partners and Abeona Therapeutics

Selected healthcare news for the capital firm - Great Point Partners, and the company - Abeona Therapeutics. We have 6 shared news items for this connection to-date.

Please provide a valid email address.
Great Point Partners Shares Healthcare News With (link):
Companies

Selected Headlines

Date Headline (link) Source Relevant Snippet
4/21/2020 Abeona Therapeutics Appoints Brian Pereira and Shawn Tomasello to the Board of Directors Globe Newswire ... industry leaders Brian Pereira as Executive Chairman and Shawn Tomasello as Independent Board Member April 21, 2020 08:00 ET Source: Abeona Therapeutics Inc. NEW YORK and CLEVELAND, April 21, 2020 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc ... Pereira and Ms. Tomasello were nominated by funds affiliated with Great Point Partners, LLC (GPP) pursuant to the previously disclosed letter agreement entered into as part of the Company’s December 24, 2019 underwritten public offering ...
12/24/2019 Abeona Announces Closing of $103.5 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Globe Newswire ... Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the closing of its underwritten public offering, with a gross offering size of approximately $103.5 million, which includes the full exercise of the underwriters’ option to purchase 5,400,000 additional shares of common stock, at a public offering price of $2.50 per share. In addition, as part of the offering, Abeona sold to Great Point ...
12/24/2019 Abeona Announces Closing of $103.5 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares | Markets Insider Business Insider ... Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the closing of its underwritten public offering, with a gross offering size of approximately $103.5 million, which includes the full exercise of the underwriters’ option to purchase 5,400,000 additional shares of common stock, at a public offering price of $2.50 per share. In addition, as part of the offering, Abeona sold to Great Point ...
12/24/2019 Abeona Announces Closing of $103.5 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Nasdaq:ABEO Globe Newswire ... Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the closing of its underwritten public offering, with a gross offering size of approximately $103.5 million, which includes the full exercise of the underwriters’ option to purchase 5,400,000 additional shares of common stock, at a public offering price of $2.50 per share. In addition, as part of the offering, Abeona sold to Great Point ...
12/20/2019 Abeona Therapeutics Announces Public Offering of Common Stock and Pre Funded Warrants Globe Newswire NEW YORK and CLEVELAND, Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that it intends to offer and sell shares of its common stock, and pre-funded ... the offering. An existing holder of the Company’s common stock, Great Point Partners (“GPP”), has indicated its intention to purchase up to $33 million in the offering, including pre-funded warrants in lieu of common ...
12/20/2019 Abeona Therapeutics Announces Public Offering of Common Stock and Pre Funded Warrants Nasdaq:ABEO Globe Newswire NEW YORK and CLEVELAND, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that it intends to offer and sell shares of its ... the offering. An existing holder of the Company’s common stock, Great Point Partners (“GPP”), has indicated its intention to purchase up to $33 million in the offering, including pre-funded warrants in lieu of common ...
12/20/2019 Abeona Announces Pricing of Public Offering of Common Stock and Pre‑Funded Warrants Globe Newswire NEW YORK and CLEVELAND, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the pricing of its public offering of 26,982,945 shares of ... closing conditions. An existing holder of the Company’s common stock, Great Point Partners (“GPP”), has agreed to purchase approximately $31 million in the offering, including pre-funded warrants in lieu of common stock, subject to ...